Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Teishima

Showing results (121-130 of 240) with videos related to

Pageof 24
Sort By:
The Prostate|January 18, 2026
Prognostic Impact of Initial Prostate Specific Antigen Half-Life After Abiraterone Acetate in High-Volume Metastatic Hormone-Sensitive Prostate Cancer: Who May Need Triplet Therapy?Kotaro Suzuki, Hideto Ueki, Naoto Wakita, et al.
Urologic Oncology|April 4, 2026
Adequate Bacillus Calmette-Guérin maintenance therapy improves recurrence-free survival in high-risk non-muscle-invasive bladder cancer: A conditional survival studyYukari Bando, Jun Teishima, Taisuke Tobe, et al.
World Journal of Urology|May 5, 2020
Indwelling catheterization, renal stones, and hydronephrosis are risk factors for symptomatic Staphylococcus aureus-related urinary tract infectionHiroyuki Kitano, Norifumi Shigemoto, Yumiko Koba, et al.
International Cancer Conference Journal|September 9, 2020
Primary adenocarcinoma of the rete testis with elevated serum CA19-9 antigen levelsHiroyuki Kitano, Kazuhiro Sentani, Keisuke Goto, et al.
The Prostate|October 17, 2018
Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patientsYohei Sekino, Naohide Oue, Shoichiro Mukai, et al.
Cancers|December 17, 2024
Utility of Machine Learning Models to Predict Lymph Node Metastasis of Japanese Localized Prostate CancerHideto Ueki, Tomoaki Terakawa, Takuto Hara, et al.
Urologic Oncology|November 13, 2024
Impact of neoadjuvant therapy on prognosis in renal cell carcinoma with inferior vena cava thrombusTakuto Hara, Kotaro Suzuki, Yasuyoshi Okamura, et al.
Oncology Reports|March 14, 2019
Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancerYohei Sekino, Naoya Sakamoto, Akira Ishikawa, et al.
International Journal of Molecular Sciences|August 16, 2019
TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate CancerYohei Sekino, Xiangrui Han, Takafumi Kawaguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 7, 2025
Prognostic Impact of the Maximal Evaluable Lesion Size in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab Combination TherapyYoshie Mita, Jun Teishima, Takuto Hara, et al.
Pageof 24

Showing results (121-130 of 240) with videos related to

Sort By:
Pageof 24
The Prostate|January 18, 2026
Prognostic Impact of Initial Prostate Specific Antigen Half-Life After Abiraterone Acetate in High-Volume Metastatic Hormone-Sensitive Prostate Cancer: Who May Need Triplet Therapy?Kotaro Suzuki, Hideto Ueki, Naoto Wakita, et al.
Urologic Oncology|April 4, 2026
Adequate Bacillus Calmette-Guérin maintenance therapy improves recurrence-free survival in high-risk non-muscle-invasive bladder cancer: A conditional survival studyYukari Bando, Jun Teishima, Taisuke Tobe, et al.
World Journal of Urology|May 5, 2020
Indwelling catheterization, renal stones, and hydronephrosis are risk factors for symptomatic Staphylococcus aureus-related urinary tract infectionHiroyuki Kitano, Norifumi Shigemoto, Yumiko Koba, et al.
International Cancer Conference Journal|September 9, 2020
Primary adenocarcinoma of the rete testis with elevated serum CA19-9 antigen levelsHiroyuki Kitano, Kazuhiro Sentani, Keisuke Goto, et al.
The Prostate|October 17, 2018
Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patientsYohei Sekino, Naohide Oue, Shoichiro Mukai, et al.
Cancers|December 17, 2024
Utility of Machine Learning Models to Predict Lymph Node Metastasis of Japanese Localized Prostate CancerHideto Ueki, Tomoaki Terakawa, Takuto Hara, et al.
Urologic Oncology|November 13, 2024
Impact of neoadjuvant therapy on prognosis in renal cell carcinoma with inferior vena cava thrombusTakuto Hara, Kotaro Suzuki, Yasuyoshi Okamura, et al.
Oncology Reports|March 14, 2019
Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancerYohei Sekino, Naoya Sakamoto, Akira Ishikawa, et al.
International Journal of Molecular Sciences|August 16, 2019
TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate CancerYohei Sekino, Xiangrui Han, Takafumi Kawaguchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 7, 2025
Prognostic Impact of the Maximal Evaluable Lesion Size in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab Combination TherapyYoshie Mita, Jun Teishima, Takuto Hara, et al.
Pageof 24